You are here: Home » PTI Stories » National » News
Business Standard

Roche launches Hemophilia A treatment drug in India

Press Trust of India  |  New Delhi 

Drug firm Roche Wednesday said it has launched Emicizumab under the brand name Hemlibra in for preventive A, an inherited in which a person's does not clot properly.

Hemlibra is the first weekly subcutaneous prophylaxis injection shown to prevent or reduce the frequency of bleeding episodes and improve the quality of life, Roche said in a statement.

All current prophylactic treatment options for people with with factor VIII inhibitors require several times a week, it added.

"The introduction of Emicizumab (Hemlibra) is a significant milestone in the A in and reaffirms our commitment to bring Roche's ground breaking medicines to patients in as early as possible," India's said.

This breakthrough medicine represents a completely new way to manage and redefines the standard of care, she added.

The company, however, did not disclose the price at which it would be selling the drug in the country.

Hemlibra is approved by multiple regulatory authorities across the world and is now also approved and available in India, the statement said.

is an inherited, in which a person's does not clot properly, leading to an uncontrolled and often spontaneous bleeding.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, April 17 2019. 14:15 IST